September 12, 2022
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ada D. Sarmento
| Re: | Ginkgo Bioworks Holdings, Inc. |
Amendment No. 1 to Registration Statement on Form S-4
Filed September 12, 2022
Registration No. 333-267241
Ladies and Gentlemen:
In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Ginkgo Bioworks Holdings, Inc. (the “Company”) hereby requests that the effective date of the above-referenced Registration Statement be accelerated to, and the Registration Statement become effective on, September 14, 2022, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable.
Please contact Marko Zatylny of Ropes & Gray LLP at marko.zatylny@ropesgray.com or (617) 951-7980, or Suni Sreepada of Ropes & Gray LLP at suni.sreepada@ropesgray.com or (212) 596-9960, to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter.
| Sincerely yours, | ||
| Ginkgo Bioworks Holdings, Inc. | ||
| By: | /s/ Jason Kelly | |
| Jason Kelly | ||
| Chief Executive Officer | ||
| cc: | Karen Tepichin, Ginkgo Bioworks Holdings, Inc. |
Marko Zatylny, Ropes & Gray LLP
Suni Sreepada, Ropes & Gray LLP
